Suppr超能文献

血管内皮特异性二甲基精氨酸二甲氨基水解酶-1 缺陷小鼠揭示血管内皮在去除非对称性二甲基精氨酸中发挥重要作用。

Vascular endothelial-specific dimethylarginine dimethylaminohydrolase-1-deficient mice reveal that vascular endothelium plays an important role in removing asymmetric dimethylarginine.

机构信息

Lillehei Heart Institute and Division of Cardiology, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.

出版信息

Circulation. 2009 Dec 1;120(22):2222-9. doi: 10.1161/CIRCULATIONAHA.108.819912. Epub 2009 Nov 16.

Abstract

BACKGROUND

Asymmetrical methylarginines inhibit NO synthase activity and thereby decrease NO production. Dimethylarginine dimethylaminohydrolase 1 (DDAH1) degrades asymmetrical methylarginines. We previously demonstrated that in the heart DDAH1 is predominantly expressed in vascular endothelial cells. Because an earlier study showed that mice with global DDAH1 deficiency experienced embryonic lethality, we speculated that a mouse strain with selective vascular endothelial DDAH1 deficiency (endo-DDAH1(-/-)) would largely abolish tissue DDAH1 expression in many tissues but possibly avoid embryonic lethality.

METHODS AND RESULTS

By using the LoxP/Cre approach, we generated the endo-DDAH1(-/-) mice. The endo-DDAH1(-/-) mice had no apparent defect in growth or development compared with wild-type littermates. DDAH1 expression was greatly reduced in kidney, lung, brain, and liver, indicating that in these organs DDAH1 is distributed mainly in vascular endothelial cells. The endo-DDAH1(-/-) mice showed a significant increase of asymmetric dimethylarginine concentration in plasma (1.41 micromol/L in the endo-DDAH1(-/-) versus 0.69 micromol/L in the control mice), kidney, lung, and liver, which was associated with significantly increased systolic blood pressure (132 mm Hg versus 113 mm Hg in wild-type). The endo-DDAH1(-/-) mice also exhibited significantly attenuated acetylcholine-induced NO production and vessel relaxation in isolated aortic rings.

CONCLUSIONS

Our study demonstrates that DDAH1 is highly expressed in vascular endothelium and that endothelial DDAH1 plays an important role in regulating blood pressure. In the context that asymmetric methylarginines are broadly produced by many type of cells, the strong DDAH1 expression in vascular endothelium demonstrates for the first time that vascular endothelium can be an important site to actively dispose of toxic biochemical molecules produced by other types of cells.

摘要

背景

非对称甲基精氨酸抑制一氧化氮合酶的活性,从而减少一氧化氮的产生。二甲基精氨酸二甲氨基水解酶 1(DDAH1)可降解非对称甲基精氨酸。我们之前的研究表明,在心脏中 DDAH1 主要在血管内皮细胞中表达。由于早期的一项研究表明,缺乏全局 DDAH1 的小鼠会经历胚胎致死,我们推测具有选择性血管内皮 DDAH1 缺乏(endo-DDAH1(-/-))的小鼠将在许多组织中基本上消除组织 DDAH1 的表达,但可能避免胚胎致死。

方法和结果

通过使用 LoxP/Cre 方法,我们产生了 endo-DDAH1(-/-) 小鼠。与野生型同窝仔相比,endo-DDAH1(-/-) 小鼠的生长和发育没有明显缺陷。DDAH1 的表达在肾脏、肺、脑和肝脏中大大降低,表明在这些器官中,DDAH1 主要分布在血管内皮细胞中。endo-DDAH1(-/-) 小鼠的血浆(endo-DDAH1(-/-) 为 1.41μmol/L,对照小鼠为 0.69μmol/L)、肾脏、肺和肝脏中的不对称二甲基精氨酸浓度显著增加,这与收缩压明显升高(野生型为 132mmHg,endo-DDAH1(-/-) 为 113mmHg)有关。endo-DDAH1(-/-) 小鼠还表现出离体主动脉环中乙酰胆碱诱导的一氧化氮产生和血管舒张明显减弱。

结论

我们的研究表明,DDAH1 在血管内皮细胞中高度表达,内皮 DDAH1 在调节血压方面起着重要作用。在广泛由多种类型的细胞产生非对称甲基精氨酸的背景下,血管内皮细胞中强烈的 DDAH1 表达首次证明,血管内皮细胞可以是积极处理其他类型细胞产生的有毒生化分子的重要部位。

相似文献

引用本文的文献

本文引用的文献

1

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验